1. Home
  2. EFOI vs OGEN Comparison

EFOI vs OGEN Comparison

Compare EFOI & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Focus Inc.

EFOI

Energy Focus Inc.

HOLD

Current Price

$2.59

Market Cap

14.9M

ML Signal

HOLD

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.90

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFOI
OGEN
Founded
1985
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.9M
3.6M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
EFOI
OGEN
Price
$2.59
$0.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
15.6K
84.3K
Earning Date
11-12-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,863,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.19
$0.82
52 Week High
$3.56
$18.90

Technical Indicators

Market Signals
Indicator
EFOI
OGEN
Relative Strength Index (RSI) 57.01 40.04
Support Level $1.93 $0.85
Resistance Level $2.14 $1.00
Average True Range (ATR) 0.23 0.07
MACD 0.04 0.01
Stochastic Oscillator 59.34 33.64

Price Performance

Historical Comparison
EFOI
OGEN

About EFOI Energy Focus Inc.

Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: